fluoxetine has been researched along with Palsy in 3 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We evaluated the following 3 widely used empirical therapies for the ability to reduce the severity of paralysis in a mouse model of EV-D68 infection: (1) human intravenous immunoglobulin (hIVIG), (2) fluoxetine, and (3) dexamethasone." | 3.85 | Evaluating Treatment Efficacy in a Mouse Model of Enterovirus D68-Associated Paralytic Myelitis. ( Clarke, P; Hixon, AM; Tyler, KL, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hixon, AM | 1 |
| Clarke, P | 1 |
| Tyler, KL | 1 |
| Bermingham, DP | 1 |
| Hardaway, JA | 1 |
| Snarrenberg, CL | 1 |
| Robinson, SB | 1 |
| Folkes, OM | 1 |
| Salimando, GJ | 1 |
| Jinnah, H | 1 |
| Blakely, RD | 1 |
| Seliger, GM | 1 |
| Hornstein, A | 1 |
3 other studies available for fluoxetine and Palsy
| Article | Year |
|---|---|
Evaluating Treatment Efficacy in a Mouse Model of Enterovirus D68-Associated Paralytic Myelitis.
Topics: Animals; Antibodies, Neutralizing; Antibodies, Viral; Dexamethasone; Disease Models, Animal; Enterov | 2017 |
Acute blockade of the Caenorhabditis elegans dopamine transporter DAT-1 by the mammalian norepinephrine transporter inhibitor nisoxetine reveals the influence of genetic modifications of dopamine signaling in vivo.
Topics: Animals; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Dopamine; Dopamine Plasma Membrane | 2016 |
Serotonin, fluoxetine, and pseudobulbar affect.
Topics: Aged; Behavior; Fluoxetine; Humans; Male; Paralysis; Serotonin Antagonists | 1989 |